Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Colorectal Neoplasms 2Sarcoma, Kaposi 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm Metastasis 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Hematologic Neoplasms 1Colorectal Cancer Metastatic 1Anemia, Refractory, with Excess of Blasts 1Acquired Immunodeficiency Syndrome 1

Interventions

Doxorubicin 15Zidovudine 12Vincristine 11Bleomycin 10Interferon alpha-2 6Cyclophosphamide 5tecogalan 4sargramostim 4Methotrexate 4Liposomes 4Leucovorin 4Filgrastim 4Etoposide 4Dexamethasone 4Cytarabine 4Fluorouracil 3interferon alfa-n1 2Valganciclovir 2Tumor Necrosis Factor-alpha 2Thalidomide 2Rituximab 2Ritonavir 2Nivolumab 2Mitoxantrone 2Isotretinoin 2Interleukin-2 2Electrocoagulation 2Didanosine 2Allopurinol 2ziconotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Acquired Immunodeficiency Syndrome × Maraviroc × Clear all
NCT01329783 2011-05-16

EuroSIDA As An External Comparator To MOTIVATE Trials

ViiV Healthcare

Completed
1,181 enrolled

Acquired Immunodeficiency Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡